Zamlifid Trademark Details

This mark is alive with a status of Fourth Extension - Granted. The last case file activity for this mark occured 7 years ago on Wednesday, July 20, 2016, according to the United State Patent & Trademark Office
Word Mark Zamlifid
Status Alive 733 — Fourth Extension - Granted

Current Owner

Bristol-Myers Squibb Company of New York, NY

View all trademarks for Bristol-Myers Squibb Company
Other Trademarks for Bristol-Myers Squibb Company
Serial Number 86017243
Status Date Wednesday, July 20, 2016
Filing Date Wednesday, July 20, 2016
Attorney Marilyn F. Kelly

Correspondent

MARILYN F. KELLY
BRISTOL-MYERS SQUIBB COMPANY
PO BOX 4000
PRINCETON, NJ 08543-4000

Case File Statements

Goods & Services Pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants and pharmaceutical antibodies

Classifications

International Class Codes
005 — Class 5 includes mainly pharmaceuticals and other preparations for medical or veterinary purposes.
U.S. Class Codes 006, 018, 044, 046, 051, 052
Status 6 — Active
Status Date Monday, July 29, 2013
Primary Code 005

You must be signed in to print.

Once signed in, look for the PDF button.